Celgene Investor
Celgene discovers, develops and commercializes innovative therapies to treat cancer and immune-inflammatory-related diseases.
.png)
Technology:
CAR-T, CAR-T therapy, Cell_Therapies
Industry:
CAR-T, Public
Headquarters:
Summit, New Jersey, United States
Founded Date:
1986-01-01
Employees Number:
10001+
Funding Status:
M&A
Number Of Exits:
31
Acquisitions Number:
Made Acquisitions, Was Acquired
Estimated Revenue:
$10B+
Register and Claim Ownership